Daré Bioscience Fails Nasdaq Bid Price Rule, Has 180 Days to Comply

Daré Bioscience's common stock fell below the $1.00 minimum bid price for 30 consecutive business days, leading to a notice from Nasdaq. The company has until March 29, 2027, to regain compliance.